Janney Montgomery Scott LLC Invests $988,000 in Oscar Health, Inc. (NYSE:OSCR)

Janney Montgomery Scott LLC acquired a new stake in Oscar Health, Inc. (NYSE:OSCR) in the 3rd quarter, HoldingsChannel.com reports. The firm acquired 46,568 shares of the company’s stock, valued at approximately $988,000.

Other institutional investors also recently bought and sold shares of the company. Wealth Enhancement Advisory Services LLC boosted its stake in shares of Oscar Health by 7.5% during the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 12,028 shares of the company’s stock worth $255,000 after acquiring an additional 844 shares in the last quarter. American International Group Inc. raised its holdings in Oscar Health by 1.3% in the 1st quarter. American International Group Inc. now owns 79,411 shares of the company’s stock worth $1,181,000 after acquiring an additional 1,009 shares during the period. Summit Trail Advisors LLC raised its holdings in Oscar Health by 5.4% in the 2nd quarter. Summit Trail Advisors LLC now owns 20,820 shares of the company’s stock worth $329,000 after acquiring an additional 1,065 shares during the period. Arizona State Retirement System lifted its position in Oscar Health by 3.7% during the 2nd quarter. Arizona State Retirement System now owns 38,059 shares of the company’s stock worth $602,000 after acquiring an additional 1,351 shares during the last quarter. Finally, Amalgamated Bank lifted its position in shares of Oscar Health by 27.7% during the 2nd quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock worth $106,000 after purchasing an additional 1,458 shares during the last quarter. 75.70% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Oscar Health

In other news, Vice Chairman Joshua Kushner purchased 276,040 shares of the business’s stock in a transaction that occurred on Monday, November 11th. The stock was purchased at an average cost of $13.58 per share, with a total value of $3,748,623.20. Following the acquisition, the insider now directly owns 5,031,262 shares of the company’s stock, valued at approximately $68,324,537.96. This trade represents a 5.80 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Thrive Partners Vii Growth Gp, purchased 420,819 shares of Oscar Health stock in a transaction on Tuesday, November 12th. The stock was purchased at an average price of $13.68 per share, for a total transaction of $5,756,803.92. Following the completion of the transaction, the director now owns 5,452,081 shares of the company’s stock, valued at approximately $74,584,468.08. This represents a 8.36 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders have purchased 1,055,478 shares of company stock valued at $14,432,852 and have sold 169,569 shares valued at $3,007,069. Company insiders own 25.11% of the company’s stock.

Oscar Health Stock Down 3.7 %

OSCR opened at $14.87 on Friday. The company has a market capitalization of $3.60 billion, a P/E ratio of -247.83 and a beta of 1.67. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.91. The firm’s fifty day moving average price is $18.20 and its two-hundred day moving average price is $18.27. Oscar Health, Inc. has a fifty-two week low of $6.93 and a fifty-two week high of $23.79.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.02). The business had revenue of $2.42 billion for the quarter, compared to the consensus estimate of $2.33 billion. Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. Oscar Health’s revenue was up 68.3% on a year-over-year basis. During the same period in the previous year, the business posted ($0.29) earnings per share. On average, analysts anticipate that Oscar Health, Inc. will post -0.01 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on OSCR shares. UBS Group began coverage on shares of Oscar Health in a research note on Monday, October 7th. They issued a “neutral” rating and a $23.00 price objective on the stock. Bank of America downgraded shares of Oscar Health from a “neutral” rating to an “underperform” rating and reduced their price target for the company from $21.00 to $13.50 in a report on Wednesday, November 6th. Finally, Piper Sandler restated an “overweight” rating and set a $28.00 price objective on shares of Oscar Health in a report on Tuesday, September 10th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $22.93.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.